Description

7-Benzyl-2-Methyl-5,6,7,8-Tetrahydro-3H-Pyrido[3,4-D]Pyrimidin-4-One is a high-purity, advanced pharmaceutical intermediate of significant importance in modern drug discovery and development. Its value lies in its role as a key synthetic building block for creating novel, biologically active compounds targeting a range of therapeutic areas. This compound is primarily needed by research institutions, pharmaceutical companies, and fine chemical manufacturers engaged in the synthesis of innovative small-molecule drugs.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of novel drug candidates, particularly in medicinal chemistry research.
• Kinase Inhibitor Development: Serves as a core scaffold for the design and production of potential kinase inhibitors, a major class of targeted cancer therapies.
• Neurological Disorder Research: Used in the development of compounds for investigating treatments for central nervous system (CNS) disorders.
• Chemical Biology Probes: Employed as a building block for creating specialized molecules used to study biological pathways and protein functions.
• Process Chemistry & Scale-Up: Supplied for route scouting, optimization, and pilot-scale production of active pharmaceutical ingredients (APIs).
• Contract Research & Manufacturing (CRO/CMO): A key material for organizations providing custom synthesis and development services to the pharmaceutical industry.

Basic Information

Product Name	7-Benzyl-2-Methyl-5,6,7,8-Tetrahydro-3H-Pyrido[3,4-D]Pyrimidin-4-One
CAS No.	62259-92-1
Molecular Formula	C16H19N3O
Molecular Weight	269.34 g/mol
Synonyms	2-Methyl-7-benzyl-5,6,7,8-tetrahydro-3H-pyrido[3,4-d]pyrimidin-4-one; 7-Benzyl-2-methyl-5,6,7,8-tetrahydro-3H-pyrido[3,4-d]pyrimidin-4(1H)-one; 2-Methyl-7-benzyl-4-oxo-3,4,5,6,7,8-hexahydro-1H-pyrido[3,4-d]pyrimidine; Pyrido[3,4-d]pyrimidin-4-one, 7-benzyl-2-methyl-5,6,7,8-tetrahydro-3H-; BMT-4-One (abbrev.); CAS 62259-92-1
EINECS	Contact for details

Quality Control

Our 7-Benzyl-2-Methyl-5,6,7,8-Tetrahydro-3H-Pyrido[3,4-D]Pyrimidin-4-One is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot undergoes rigorous analytical testing, including HPLC for assay and impurity profiling, to meet the stringent requirements of pharmaceutical R&D and production. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and related substances is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider conditions under an inert atmosphere to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.